Log in

Danaher Stock Forecast, Price & News

+1.09 (+0.49 %)
(As of 12/4/2020 12:00 AM ET)
Today's Range
Now: $224.43
50-Day Range
MA: $229.31
52-Week Range
Now: $224.43
Volume2.52 million shs
Average Volume2.87 million shs
Market Capitalization$159.43 billion
P/E Ratio45.43
Dividend Yield0.32%
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Danaher logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.15 out of 5 stars

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryIndustrial Conglomerates



Sales & Book Value

Annual Sales$17.91 billion
Cash Flow$6.42 per share
Book Value$48.85 per share


Net Income$3.01 billion


Market Cap$159.43 billion
Next Earnings Date2/4/2021 (Estimated)
+1.09 (+0.49 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Danaher (NYSE:DHR) Frequently Asked Questions

How has Danaher's stock price been impacted by COVID-19 (Coronavirus)?

Danaher's stock was trading at $139.37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, DHR shares have increased by 61.0% and is now trading at $224.43.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Danaher?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Danaher
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Danaher?

Wall Street analysts have given Danaher a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Danaher wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Danaher

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) released its quarterly earnings data on Thursday, October, 22nd. The conglomerate reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.36. The conglomerate had revenue of $5.90 billion for the quarter, compared to analysts' expectations of $5.51 billion. Danaher had a net margin of 18.05% and a return on equity of 12.94%. The company's quarterly revenue was up 17.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.06 EPS.
View Danaher's earnings history

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher declared a quarterly dividend on Tuesday, September 15th. Stockholders of record on Monday, September 28th will be given a dividend of $0.18 per share on Friday, October 30th. This represents a $0.72 annualized dividend and a dividend yield of 0.32%. The ex-dividend date is Friday, September 25th.
View Danaher's dividend history

What price target have analysts set for DHR?

14 analysts have issued 12-month target prices for Danaher's stock. Their forecasts range from $169.00 to $280.00. On average, they anticipate Danaher's share price to reach $217.69 in the next twelve months. This suggests that the stock has a possible downside of 3.0%.
View analysts' price targets for Danaher

Are investors shorting Danaher?

Danaher saw a increase in short interest during the month of October. As of October 30th, there was short interest totaling 6,020,000 shares, an increase of 13.6% from the October 15th total of 5,300,000 shares. Based on an average daily trading volume, of 2,170,000 shares, the short-interest ratio is presently 2.8 days. Currently, 1.0% of the shares of the stock are sold short.
View Danaher's Short Interest

Who are some of Danaher's key competitors?

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), The Home Depot (HD), The Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

Who are Danaher's key executives?

Danaher's management team includes the following people:
  • Mr. Steven M. Rales, Co-Founder & Chairman (Age 69)
  • Mr. Rainer M. Blair, Pres, CEO & Director (Age 56, Pay $2.56M)
  • Mr. Mitchell P. Rales, Co-Founder & Director (Age 63)
  • Mr. Matthew R. McGrew, CFO & Exec. VP (Age 48, Pay $1.92M)
  • Mr. Thomas P. Joyce Jr., Sr. Advisor (Age 59, Pay $5.87M)
  • Mr. Joakim Weidemanis, Exec. VP (Age 51, Pay $2.26M)
  • Mr. Robert S. Lutz, Chief Accounting Officer & Sr. VP (Age 62)
  • Mr. Matthew E. Gugino C.F.A., CPA, CFA, CPA, VP of Investor Relations
  • Mr. Brian W. Ellis, Sr. VP, Gen. Counsel & Chief Compliance Officer (Age 53)
  • Mr. Daniel A. Raskas J.D., Sr. VP of Corp. Devel. (Age 53)

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a number of retail and institutional investors. Top institutional investors include UBS Asset Management Americas Inc. (0.60%), Nuveen Asset Management LLC (0.48%), Charles Schwab Investment Management Inc. (0.42%), Fisher Asset Management LLC (0.41%), Swiss National Bank (0.40%) and CIBC Private Wealth Group LLC (0.38%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC, Findlay Park Partners LLP, Epoch Investment Partners Inc., TD Asset Management Inc., Nuveen Asset Management LLC, PGGM Investments, AQR Capital Management LLC, and KBC Group NV. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel, and William King.
View insider buying and selling activity for Danaher

Which institutional investors are buying Danaher stock?

DHR stock was acquired by a variety of institutional investors in the last quarter, including Alps Advisors Inc., CIBC Private Wealth Group LLC, Bradley Foster & Sargent Inc. CT, Candriam Luxembourg S.C.A., AXA S.A., Teacher Retirement System of Texas, DekaBank Deutsche Girozentrale, and BP PLC.
View insider buying and selling activity for Danaher

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $224.43.

How big of a company is Danaher?

Danaher has a market capitalization of $159.43 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis. Danaher employs 60,000 workers across the globe.

What is Danaher's official website?

The official website for Danaher is www.danaher.com.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]

This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.